Skip to Content

Onconase Approval Status

Onconase (ranpirnase) is a ribonuclease enzyme in development for the treatment of unresectable malignant mesothelioma.

Development Status and FDA Approval Process for Onconase

Jan 28, 2009Alfacell Provides Onconase NDA Submission Update - Jan 28, 2009
Dec  8, 2008Alfacell Provides Onconase NDA Submission Update - Dec 8, 2008
Oct  2, 2006Alfacell Completes Non-Clinical Section of Rolling NDA for Lead Anticancer Drug Onconase

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.